UWA-101 (also known as α-cyclopropyl-MDMA) is a phenethylamine derivative invented at the University of Western Australia and researched as a potential treatment for Parkinson’s disease. Its chemical structure is very similar to that of the illegal drug MDMA, the only difference being the replacement of the α-methyl group with an α-cyclopropyl group. MDMA has been found in animal studies and reported in unauthorised human self-experiments to be effective in the short-term relief of Parkinson’s disease symptoms, especially when used alongside conventional treatment with L-DOPA.
: It’s legal analog of MDMA
IUPAC name: 2-(1,3-benzodioxol-5-yl)-1-cyclopropyl-N-methylethanamine
Purity: 99,9% min
Appearance: white powder